Cell Culture Market by Consumables (Serum free media  FBS  ABS)  Equipment  Bioreactor  Supporting Equipment (Centrifuge  Filtration System)  Application (Biopharmaceutical  Cancer Research)  End Users (Pharma  Research) - Global Forecast to 2023

Cell Culture Market by Consumables (Serum free media FBS ABS) Equipment Bioreactor Supporting Equipment (Centrifuge Filtration System) Application (Biopharmaceutical Cancer Research) End Users (Pharma Research) - Global Forecast to 2023

MarketsandMarkets | ID: 1524216365098 | Published at: 2018-04-13 | Pages: 248

  • €4.785,63


“The global cell culture market projected to grow at a CAGR of 11.4%.”

The global cell culture market is expected to reach USD 26.28 billion by 2023 from USD 15.32 billion in 2018, at a CAGR of 11.4%. Growth in this market is driven by the growing number of regulatory approvals for cell culture-based vaccines, increasing demand for monoclonal antibodies (mAbs), funding for cell-based research, growing preference for single-use technologies, and the launch of advanced cell culture products. On the other hand, the high cost of cell biology research and the lack of proper infrastructure for cell-based research activities are the major factors restraining the growth of this market.

“Consumables are expected to grow at the highest CAGR during the forecast period.”

Based on product, the cell culture market is segmented into equipment and consumables. The consumables segment accounted for the largest market share in 2017 and is expected to register the highest CAGR during the forecast period. The repeated purchase of consumables for various cell culture applications is the major factor supporting the growth of the consumables segment during the forecast period.

“Pharmaceutical and biotechnology companies are expected to dominate the market during the forecast period.”

Based on end user, the cell culture market is segmented into pharmaceutical and biotechnology companies and research institutes. The pharmaceutical and biotechnology companies segment accounted for the largest market share in 2017 and is projected to register the highest CAGR during the forecast period. The growing use of single-use technologies, increasing number of regulatory approvals for cell culture-based vaccines, and presence of a large number of pharmaceutical players in this market are driving the cell culture market for this end-user segment.

“Asia to witness the highest growth during the forecast period.”

In 2018, North America is expected to account for the largest share of the market followed by Europe. However, Asia is expected to register the highest CAGR during the forecast period. The high growth in the Asian market is attributed to factors such as favorable regulatory guidelines, lower manufacturing costs, growing presence of market players in emerging economies, and favorable government investments in the life sciences sector.

The primary interviews conducted for this report can be categorized as follows:
• By Company Type: Tier 1 – 36%; Tier 2 – 46%; Tier 3 – 18%.
• By Designation: C-level- 29%; D-level- 43%; Others- 28%.
• By Region: North America-39%; Europe-29%; Asia 20%; Rest of the World 12%
List of companies profiled in the report
• Thermo Fisher Scientific (US)
• Merck KGaA (Germany)
• GE Healthcare (US)
• Lonza (Switzerland)
• Becton, Dickinson and Company (US)
• Corning Incorporated (US)
• Eppendorf AG (Germany)
• HiMedia Laboratories (India)
• Sartorius AG (Germany)
• PromoCell GmbH (Germany)
• Danaher Corporation (US)
• Irvine Scientific (US)
• InvivoGen (US)
• CellGenix GmbH (Germany)
• Miltenyi Biotec (Germany)
Research Coverage:
The report provides an overview of the cell culture market. It aims at estimating the market size and future growth potential of this market across different segments such as product, application, end user, and region. Furthermore, the report also includes an in-depth competitive analysis of the key players in the market along with their company profiles, recent developments, and key market strategies.

Key Benefits of Buying the Report:
The report will help the market leaders/new entrants in this market by providing them with the closest approximations of revenues for the overall cell culture market and its subsegments. This report will help stakeholders to understand the competitive landscape better and gain insights to position their businesses and help companies make suitable go-to-market strategies. The report will also help stakeholders understand the pulse of the market and provide them with information regarding key market drivers and opportunities.

TABLE OF CONTENTS

1 INTRODUCTION 21

  • 1.1 OBJECTIVES OF THE STUDY 21
  • 1.2 MARKET DEFINITION 21
  • 1.3 MARKET SCOPE 22
    • 1.3.1 MARKETS COVERED 22
    • 1.3.2 YEARS CONSIDERED FOR THE STUDY 23
  • 1.4 CURRENCY 23
  • 1.5 LIMITATION 23
  • 1.6 STAKEHOLDERS 23
    2 RESEARCH METHODOLOGY 24
  • 2.1 RESEARCH DATA 24
  • 2.2 SECONDARY DATA 25
    • 2.2.1 SECONDARY SOURCE 25
  • 2.3 PRIMARY DATA 26
    • 2.3.1 KEY DATA FROM PRIMARY SOURCES 26
    • 2.3.2 KEY INDUSTRY INSIGHTS 28
  • 2.4 MARKET SIZE ESTIMATION 29
  • 2.5 MARKET BREAKDOWN AND DATA TRIANGULATION 31
  • 2.6 ASSUMPTIONS FOR THE STUDY 32
    3 EXECUTIVE SUMMARY 33
    4 PREMIUM INSIGHTS 37
  • 4.1 CELL CULTURE: MARKET OVERVIEW 37
  • 4.2 EUROPE: CELL CULTURE VESSELS MARKET, BY TYPE (2017) 38
  • 4.3 CELL CULTURE SERA, MEDIA, AND REAGENTS MARKET, BY TYPE 39
  • 4.4 CELL CULTURE MARKET, BY APPLICATION, 2018 VS. 2023 (USD BILLION) 39
  • 4.5 CELL CULTURE MARKET, BY END USER, 2018 VS.2023 (USD BILLION) 40
  • 4.6 GEOGRAPHICAL SNAPSHOT OF THE CELL CULTURE MARKET 40
    5 MARKET OVERVIEW 41
  • 5.1 INTRODUCTION 41
  • 5.2 MARKET DYNAMICS 41
    • 5.2.1 MARKET DRIVERS 42
      • 5.2.1.1 Growing awareness about the benefits of cell culture-based vaccines 42
      • 5.2.1.2 Increasing demand for monoclonal antibodies 42
  • 5.2.1.3 Funding for cell-based research 42
  • 5.2.1.4 Growing preference for single-use technologies 43
  • 5.2.1.5 Launch of advanced cell culture products 43
  • 5.2.2 MARKET RESTRAINTS 44
    • 5.2.2.1 High cost of cell biology research 44
    • 5.2.2.2 Lack of infrastructure for cell-based research in emerging economies 44
  • 5.2.3 MARKET OPPORTUNITIES 44
    • 5.2.3.1 Growing demand for 3D cell culture 44
    • 5.2.3.2 Increased risk of pandemics and communicable diseases 45
    • 5.2.3.3 Emerging economies 45
  • 5.2.4 MARKET CHALLENGES 45
    • 5.2.4.1 Survival of new entrants 45
      6 CELL CULTURE MARKET, BY PRODUCT 46
  • 6.1 INTRODUCTION 47
  • 6.2 EQUIPMENT 48
    • 6.2.1 BIOREACTORS 50
      • 6.2.1.1 Conventional bioreactors 52
      • 6.2.1.2 Single-use bioreactors 53
    • 6.2.2 VESSELS 54
      • 6.2.2.1 Flasks 56
      • 6.2.2.2 Roller/roux bottles 57
      • 6.2.2.3 Cell factory systems/cell stacks 58
      • 6.2.2.4 Petri dishes 59
      • 6.2.2.5 Multiwell plates 60
    • 6.2.3 STORAGE EQUIPMENT 61
      • 6.2.3.1 Refrigerators and freezers 63
      • 6.2.3.2 Cryostorage Systems 64
    • 6.2.4 SUPPORTING EQUIPMENT 65
      • 6.2.4.1 Cell counters 67
      • 6.2.4.2 Filtration systems 68
      • 6.2.4.3 Centrifuges 69
      • 6.2.4.4 CO2 Incubators 70
      • 6.2.4.5 Autoclaves 72
      • 6.2.4.6 Microscopes 73
      • 6.2.4.7 Biosafety cabinets 74
      • 6.2.4.8 Other cell culture supporting equipment 75
  • 6.3 CONSUMABLES 77
    • 6.3.1 SERA, MEDIA, AND REAGENTS 79
      • 6.3.1.1 Sera 80

  • 6.3.1.1.1 Fetal bovine sera (FBS) 82
  • 6.3.1.1.2 Adult bovine sera (ABS) 83
  • 6.3.1.1.3 Other animal sera 84
  • 6.3.1.2 Media 85
    • 6.3.1.2.1 Classical media & salts 87
    • 6.3.1.2.2 Serum-free media 88
    • 6.3.1.2.3 Specialty media 89
    • 6.3.1.2.4 Stem cell culture media 90
  • 6.3.1.3 Cell culture reagents 91
    • 6.3.1.3.1 Supplements and growth factors 92
    • 6.3.1.3.2 Buffers and chemicals 93
    • 6.3.1.3.3 Cell dissociation reagents 94
    • 6.3.1.3.4 Balanced salt solutions 96
    • 6.3.1.3.5 Cryoprotective reagents 97
    • 6.3.1.3.6 Contamination detection kits 98
    • 6.3.1.3.7 Antibiotics/Antimycotics 99
    • 6.3.1.3.8 Attachment & matrix factors 100
    • 6.3.1.3.9 Other cell culture reagents 101
  • 6.3.2 CELL CULTURE BIOREACTOR ACCESSORIES 102
    7 CELL CULTURE MARKET, BY APPLICATION 103
  • 7.1 INTRODUCTION 104
  • 7.2 BIOPHARMACEUTICAL/THERAPEUTIC APPLICATIONS 105
    • 7.2.1 VACCINE PRODUCTION 107
    • 7.2.2 DIAGNOSTICS 109
    • 7.2.3 RECOMBINANT THERAPEUTIC PROTEINS 110
  • 7.3 CANCER RESEARCH 112
  • 7.4 STEM CELL TECHNOLOGIES 114
  • 7.5 DRUG SCREENING & DEVELOPMENT 115
  • 7.6 TISSUE ENGINEERING & REGENERATIVE MEDICINE 117
  • 7.7 OTHER APPLICATIONS 119
    8 CELL CULTURE MARKET, BY END USER 121
  • 8.1 INTRODUCTION 122
  • 8.2 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES 122
  • 8.3 RESEARCH INSTITUTES 124
    9 CELL CULTURE MARKET, BY REGION 127
  • 9.1 INTRODUCTION 128
  • 9.2 NORTH AMERICA 129
    • 9.2.1 US 135
    • 9.2.2 CANADA 141
  • 9.3 EUROPE 148
    • 9.3.1 GERMANY 155
    • 9.3.2 FRANCE 158
    • 9.3.3 UK 161
    • 9.3.4 ROE 163
  • 9.4 ASIA 166
  • 9.5 REST OF THE WORLD (ROW) 175
    10 COMPETITIVE LANDSCAPE 183
  • 10.1 OVERVIEW 183
  • 10.2 MARKET SHARE ANALYSIS, 2017 185
  • 10.3 COMPETITIVE SCENARIO 187
    • 10.3.1 PARTNERSHIPS, AGREEMENTS, AND COLLABORATIONS (2014–2018) 187
    • 10.3.2 PRODUCT LAUNCHES (2014–2018) 187
    • 10.3.3 EXPANSIONS (2014–2018) 188
    • 10.3.4 ACQUISITIONS (2014–2018) 188
      11 COMPANY PROFILES 189
      (Business Overview, Products Offered, Recent Developments, SWOT Analysis, MnM View)*
  • 11.1 THERMO FISHER SCIENTIFIC 189
  • 11.2 MERCK KGAA 194
  • 11.3 GE HEALTHCARE (A SUBSIDIARY OF GENERAL ELECTRIC COMPANY) 201
  • 11.4 LONZA GROUP AG 206
  • 11.5 CORNING 211
  • 11.6 BECTON, DICKINSON AND COMPANY 214
  • 11.7 EPPENDORF 216
  • 11.8 HI-MEDIA LABORATORIES 219
  • 11.9 SARTORIUS AG 225
  • 11.10 PROMOCELL 228
  • 11.11 IRVINE SCIENTIFIC 230
  • 11.12 DANAHER 232
  • 11.13 INVIVOGEN 235
  • 11.14 CELLGENIX 236
  • 11.15 MILTENYI BIOTECH 238
*Business Overview, Products Offered, Recent Developments, SWOT Analysis, MnM View might not be captured in case of unlisted companies.

12 APPENDIX 240

  • 12.1 INSIGHTS FROM INDUSTRY EXPERTS 240
  • 12.2 DISCUSSION GUIDE 241
  • 12.3 INTRODUCING RT: REAL-TIME MARKET INTELLIGENCE 245
  • 12.4 AVAILABLE CUSTOMIZATION 245
  • 12.5 RELATED REPORTS 246
  • 12.6 AUTHOR DETAILS 247

LIST OF TABLES

TABLE 1 US GOVERNMENT FUNDING FOR STEM CELL RESEARCH 43
TABLE 2 CELL CULTURE MARKET, BY PRODUCT, 2016–2023 (USD MILLION) 48
TABLE 3 CELL CULTURE EQUIPMENT MARKET, BY TYPE, 2016–2023 (USD MILLION) 48
TABLE 4 CELL CULTURE EQUIPMENT MARKET, BY REGION, 2016–2023 (USD MILLION) 49
TABLE 5 NORTH AMERICA: CELL CULTURE EQUIPMENT MARKET, BY COUNTRY,
2016–2023 (USD MILLION) 49
TABLE 6 EUROPE: CELL CULTURE EQUIPMENT MARKET, BY COUNTRY,
2016–2023 (USD MILLION) 49
TABLE 7 CELL CULTURE BIOREACTORS MARKET, BY TYPE, 2016–2023 (USD MILLION) 50
TABLE 8 CELL CULTURE BIOREACTORS MARKET, BY REGION, 2016–2023 (USD MILLION) 50
TABLE 9 NORTH AMERICA: CELL CULTURE BIOREACTORS MARKET, BY COUNTRY,
2016–2023 (USD MILLION) 51
TABLE 10 EUROPE: CELL CULTURE BIOREACTORS MARKET, BY COUNTRY,
2016–2023 (USD MILLION) 51
TABLE 11 CONVENTIONAL BIOREACTORS MARKET, BY REGION, 2016–2023 (USD MILLION) 52
TABLE 12 NORTH AMERICA: CONVENTIONAL BIOREACTORS MARKET, BY COUNTRY,
2016–2023 (USD MILLION) 52
TABLE 13 SINGLE-USE BIOREACTORS MARKET, BY REGION, 2016–2023 (USD MILLION) 53
TABLE 14 NORTH AMERICA: SINGLE-USE BIOREACTORS MARKET, BY COUNTRY,
2015–2022 (USD MILLION) 54
TABLE 15 CELL CULTURE VESSELS MARKET, BY TYPE, 2016–2023 (USD MILLION) 54
TABLE 16 CELL CULTURE VESSELS MARKET, BY REGION, 2016–2023 (USD MILLION) 55
TABLE 17 NORTH AMERICA: CELL CULTURE VESSELS MARKET, BY COUNTRY,
2016–2023 (USD MILLION) 55
TABLE 18 EUROPE: CELL CULTURE VESSELS MARKET, BY COUNTRY,
2016–2023 (USD MILLION) 55
TABLE 19 FLASKS MARKET, BY REGION, 2016–2023 (USD MILLION) 56
TABLE 20 NORTH AMERICA: FLASKS MARKET, BY COUNTRY, 2016–2023 (USD MILLION) 56
TABLE 21 ROLLER/ROUX BOTTLES MARKET, BY REGION, 2016–2023 (USD MILLION) 57
TABLE 22 NORTH AMERICA: ROLLER/ROUX BOTTLES MARKET, BY COUNTRY,
2016–2023 (USD MILLION) 57
TABLE 23 CELL FACTORY SYSTEMS/CELL STACKS MARKET, BY REGION,
2016–2023 (USD MILLION) 58
TABLE 24 NORTH AMERICA: CELL FACTORY SYSTEMS/CELL STACKS MARKET, BY COUNTRY, 2016–2023 (USD MILLION) 58
TABLE 25 PETRI DISHES MARKET, BY REGION, 2016–2023 (USD MILLION) 59
TABLE 26 NORTH AMERICA: PETRI DISHES MARKET, BY COUNTRY,
2016–2023 (USD MILLION) 59
TABLE 27 MULTIWELL PLATES MARKET, BY REGION, 2016–2023 (USD MILLION) 60
TABLE 28 NORTH AMERICA: MULTIWELL PLATES MARKET, BY COUNTRY,
2016–2023 (USD MILLION) 60
TABLE 29 CELL CULTURE STORAGE EQUIPMENT MARKET, BY TYPE,
2016–2023 (USD MILLION) 61
TABLE 30 CELL CULTURE STORAGE EQUIPMENT MARKET, BY REGION,
2016–2023 (USD MILLION) 61
TABLE 31 NORTH AMERICA: CELL CULTURE STORAGE EQUIPMENT MARKET, BY COUNTRY, 2016–2023 (USD MILLION) 62
TABLE 32 EUROPE: CELL CULTURE STORAGE EQUIPMENT MARKET, BY COUNTRY,
2016–2023 (USD MILLION) 62
TABLE 33 REFRIGERATORS & FREEZERS MARKET, BY REGION, 2016–2023 (USD MILLION) 63
TABLE 34 NORTH AMERICA: REFRIGERATORS & FREEZERS MARKET, BY COUNTRY,
2016–2023 (USD MILLION) 63
TABLE 35 CRYOSTORAGE SYSTEMS MARKET, BY REGION, 2016–2023 (USD MILLION) 64
TABLE 36 NORTH AMERICA: CRYOSTORAGE SYSTEMS MARKET, BY COUNTRY,
2016–2023 (USD MILLION) 65
TABLE 37 CELL CULTURE SUPPORTING EQUIPMENT MARKET, BY TYPE,
2016–2023 (USD MILLION) 65
TABLE 38 CELL CULTURE SUPPORTING EQUIPMENT MARKET, BY REGION,
2016–2023 (USD MILLION) 66
TABLE 39 NORTH AMERICA: CELL CULTURE SUPPORTING EQUIPMENT MARKET, BY COUNTRY 2016–2023 (USD MILLION) 66
TABLE 40 EUROPE: CELL CULTURE SUPPORTING EQUIPMENT MARKET, BY COUNTRY
2016–2023 (USD MILLION) 66
TABLE 41 CELL COUNTERS MARKET, BY REGION, 2016–2023 (USD MILLION) 67
TABLE 42 NORTH AMERICA: CELL COUNTERS MARKET, BY COUNTRY,
2016–2023 (USD MILLION) 68
TABLE 43 FILTRATION SYSTEMS MARKET, BY REGION, 2016–2023 (USD MILLION) 68
TABLE 44 NORTH AMERICA: FILTRATION SYSTEMS MARKET, BY COUNTRY,
2016–2023 (USD MILLION) 69
TABLE 45 CENTRIFUGES MARKET, BY REGION, 2016–2023 (USD MILLION) 70
TABLE 46 NORTH AMERICA: CENTRIFUGES MARKET, BY COUNTRY,
2016–2023 (USD MILLION) 70
TABLE 47 CO2 INCUBATORS MARKET, BY REGION, 2016–2023 (USD MILLION) 71
TABLE 48 NORTH AMERICA: CO2 INCUBATORS MARKET, BY COUNTRY,
2016–2023 (USD MILLION) 71
TABLE 49 AUTOCLAVES MARKET, BY REGION, 2016–2023 (USD MILLION) 72
TABLE 50 NORTH AMERICA: AUTOCLAVES MARKET, BY COUNTRY,
2016–2023 (USD MILLION) 72
TABLE 51 MICROSCOPES MARKET, BY REGION, 2016–2023 (USD MILLION) 73
TABLE 52 NORTH AMERICA: MICROSCOPES MARKET, BY COUNTRY,
2016–2023 (USD MILLION) 73
TABLE 53 BIOSAFETY CABINETS MARKET, BY REGION, 2016–2023 (USD MILLION) 74
TABLE 54 NORTH AMERICA: BIOSAFETY CABINETS MARKET, BY COUNTRY,
2016–2023 (USD MILLION) 75
TABLE 55 OTHER CELL CULTURE SUPPORTING EQUIPMENT MARKET, BY REGION,
2016–2023 (USD MILLION) 76
TABLE 56 NORTH AMERICA: OTHER CELL CULTURE SUPPORTING EQUIPMENT MARKET,
BY COUNTRY, 2016–2023 (USD MILLION) 76
TABLE 57 CELL CULTURE CONSUMABLES MARKET, BY TYPE, 2016–2023 (USD MILLION) 77
TABLE 58 CELL CULTURE CONSUMABLES MARKET, BY REGION, 2016–2023 (USD MILLION) 77
TABLE 59 NORTH AMERICA: CELL CULTURE CONSUMABLES MARKET, BY COUNTRY,
2016–2023 (USD MILLION) 78
TABLE 60 EUROPE: CELL CULTURE CONSUMABLES MARKET, BY COUNTRY,
2016–2023 (USD MILLION) 78
TABLE 61 CELL CULTURE SERA, MEDIA, AND REAGENTS MARKET, BY TYPE,
2016–2023 (USD MILLION) 79
TABLE 62 CELL CULTURE SERA, MEDIA, AND REAGENTS MARKET, BY REGION,
2016–2023 (USD MILLION) 79
TABLE 63 NORTH AMERICA: CELL CULTURE SERA, MEDIA, AND REAGENTS MARKET,
BY COUNTRY, 2016–2023 (USD MILLION) 80
TABLE 64 EUROPE: CELL CULTURE SERA, MEDIA, AND REAGENTS MARKET,
BY COUNTRY, 2016–2023 (USD MILLION) 80
TABLE 65 CELL CULTURE SERA MARKET, BY TYPE, 2016–2023 (USD MILLION) 81
TABLE 66 CELL CULTURE SERA MARKET, BY REGION, 2016–2023 (USD MILLION) 81
TABLE 67 NORTH AMERICA: CELL CULTURE SERA MARKET, BY COUNTRY,
2016–2023 (USD MILLION) 82
TABLE 68 FETAL BOVINE SERA MARKET, BY REGION, 2016–2023 (USD MILLION) 83
TABLE 69 NORTH AMERICA: FETAL BOVINE SERA MARKET, BY COUNTRY,
2016–2023 (USD MILLION) 83
TABLE 70 ADULT BOVINE SERA MARKET, BY REGION, 2016–2023 (USD MILLION) 84
TABLE 71 NORTH AMERICA: ADULT BOVINE SERA MARKET, BY COUNTRY,
2016–2023 (USD MILLION) 84
TABLE 72 OTHER ANIMAL SERA MARKET, BY REGION, 2016–2023 (USD MILLION) 85
TABLE 73 NORTH AMERICA: OTHER ANIMAL SERA MARKET, BY COUNTRY,
2016–2023 (USD MILLION) 85
TABLE 74 CELL CULTURE MEDIA MARKET, BY TYPE, 2016–2023 (USD MILLION) 86
TABLE 75 CELL CULTURE MEDIA MARKET, BY REGION, 2016–2023 (USD MILLION) 86
TABLE 76 NORTH AMERICA: CELL CULTURE MEDIA MARKET, BY COUNTRY,
2016–2023 (USD MILLION) 86
TABLE 77 CLASSICAL MEDIA & SALTS MARKET, BY REGION, 2016–2023 (USD MILLION) 87
TABLE 78 NORTH AMERICA: CLASSICAL MEDIA & SALTS MARKET, BY COUNTRY,
2016–2023 (USD MILLION) 87
TABLE 79 SERUM-FREE MEDIA MARKET, BY REGION, 2016–2023 (USD MILLION) 88
TABLE 80 NORTH AMERICA: SERUM-FREE MEDIA MARKET, BY COUNTRY,
2016–2023 (USD MILLION) 89
TABLE 81 SPECIALTY MEDIA MARKET, BY REGION, 2016–2023 (USD MILLION) 89
TABLE 82 NORTH AMERICA: SPECIALTY MEDIA MARKET, BY COUNTRY,
2016–2023 (USD MILLION) 90
TABLE 83 STEM CELL CULTURE MEDIA MARKET, BY REGION, 2016–2023 (USD MILLION) 90
TABLE 84 NORTH AMERICA: STEM CELL CULTURE MEDIA MARKET, BY COUNTRY,
2016–2023 (USD MILLION) 91
TABLE 85 CELL CULTURE REAGENTS MARKET, BY TYPE, 2016–2023 (USD MILLION) 91
TABLE 86 CELL CULTURE REAGENTS MARKET, BY REGION, 2016–2023 (USD MILLION) 92
TABLE 87 NORTH AMERICA: CELL CULTURE REAGENTS MARKET, BY COUNTRY,
2016–2023 (USD MILLION) 92
TABLE 88 SUPPLEMENTS AND GROWTH FACTORS MARKET, BY REGION,
2016–2023 (USD MILLION) 93
TABLE 89 NORTH AMERICA: SUPPLEMENTS AND GROWTH FACTORS MARKET, BY COUNTRY, 2016–2023 (USD MILLION) 93
TABLE 90 BUFFERS & CHEMICALS MARKET, BY REGION, 2016–2023 (USD MILLION) 94
TABLE 91 NORTH AMERICA: BUFFERS & CHEMICALS MARKET, BY COUNTRY,
2016–2023 (USD MILLION) 94
TABLE 92 CELL DISSOCIATION REAGENTS MARKET, BY REGION, 2016–2023 (USD MILLION) 95
TABLE 93 NORTH AMERICA: CELL DISSOCIATION REAGENTS MARKET, BY COUNTRY,
2016–2023 (USD MILLION) 95
TABLE 94 BALANCED SALT SOLUTIONS MARKET, BY REGION, 2016–2023 (USD MILLION) 96
TABLE 95 NORTH AMERICA: BALANCED SALT SOLUTIONS MARKET, BY COUNTRY,
2016–2023 (USD MILLION) 96
TABLE 96 CRYOPROTECTIVE REAGENTS MARKET, BY REGION, 2016–2023 (USD MILLION) 97
TABLE 97 NORTH AMERICA: CRYOPROTECTIVE REAGENTS MARKET, BY COUNTRY,
2016–2023 (USD MILLION) 97
TABLE 98 CONTAMINATION DETECTION KITS MARKET, BY REGION,
2016–2023 (USD MILLION) 98
TABLE 99 NORTH AMERICA: CONTAMINATION DETECTION KITS MARKET, BY COUNTRY, 2016–2023 (USD MILLION) 98
TABLE 100 ANTIBIOTICS/ANTIMYCOTICS MARKET, BY REGION, 2016–2023 (USD MILLION) 99
TABLE 101 ANTIBIOTICS/ANTIBIOTICS MARKET, BY COUNTRY, 2016–2023 (USD MILLION) 99
TABLE 102 ATTACHMENT & MATRIX FACTORS MARKET, BY REGION,
2016–2023 (USD MILLION) 100
TABLE 103 NORTH AMERICA: ATTACHMENT & MATRIX FACTORS, MARKET, BY COUNTRY, 2016–2023 (USD MILLION) 100
TABLE 104 OTHER CELL CULTURE REAGENTS MARKET, BY REGION,
2016–2023 (USD MILLION) 101
TABLE 105 NORTH AMERICA: OTHER CELL CULTURE REAGENTS MARKET, BY COUNTRY, 2016–2023 (USD MILLION) 101
TABLE 106 CELL CULTURE BIOREACTOR ACCESSORIES MARKET, BY REGION,
2016–2023 (USD MILLION) 102
TABLE 107 NORTH AMERICA: CELL CULTURE BIOREACTOR ACCESSORIES MARKET,
BY COUNTRY, 2016–2023 (USD MILLION) 102
TABLE 108 CELL CULTURE MARKET, BY APPLICATION, 2018-2023 (USD MILLION) 104
TABLE 109 CELL CULTURE MARKET FOR BIOPHARMACEUTICAL/THERAPEUTIC APPLICATIONS, BY TYPE, 2018-2023 (USD MILLION) 105
TABLE 110 CELL CULTURE MARKET FOR BIOPHARMACEUTICAL/THERAPEUTIC APPLICATIONS, BY REGION, 2018-2023 (USD MILLION) 105
TABLE 111 NORTH AMERICA: CELL CULTURE MARKET FOR BIOPHARMACEUTICAL/THERAPEUTIC APPLICATIONS, BY COUNTRY,
2018-2023 (USD MILLION) 106
TABLE 112 EUROPE: CELL CULTURE MARKET FOR BIOPHARMACEUTICAL/THERAPEUTIC APPLICATIONS, BY COUNTRY, 2018-2023 (USD MILLION) 106
TABLE 113 VACCINE PRODUCTION MARKET, BY REGION, 2018-2023 (USD MILLION) 107
TABLE 114 NORTH AMERICA: VACCINE PRODUCTION MARKET, BY COUNTRY,
2018-2023 (USD MILLION) 108
TABLE 115 EUROPE: VACCINE PRODUCTION MARKET, BY COUNTRY,
2018-2023 (USD MILLION) 108
TABLE 116 DIAGNOSTICS MARKET, BY REGION, 2018-2023 (USD MILLION) 109
TABLE 117 NORTH AMERICA: DIAGNOSTICS MARKET, BY COUNTRY,
2018-2023 (USD MILLION) 109
TABLE 118 EUROPE: DIAGNOSTICS MARKET, BY COUNTRY, 2018-2023 (USD MILLION) 110
TABLE 119 RECOMBINANT THERAPEUTIC PROTEINS MARKET, BY REGION,
2018-2023 (USD MILLION) 111
TABLE 120 NORTH AMERICA: RECOMBINANT THERAPEUTIC PROTEINS MARKET, BY COUNTRY, 2018-2023 (USD MILLION) 111
TABLE 121 EUROPE: RECOMBINANT THERAPEUTIC PROTEINS MARKET, BY COUNTRY,
2018-2023 (USD MILLION) 111
TABLE 122 CELL CULTURE MARKET FOR CANCER RESEARCH, BY REGION,
2018-2023 (USD MILLION) 112
TABLE 123 NORTH AMERICA: CANCER RESEARCH MARKET, BY COUNTRY,
2018-2023 (USD MILLION) 113
TABLE 124 EUROPE: CANCER RESEARCH MARKET, BY COUNTRY, 2018-2023 (USD MILLION) 113
TABLE 125 CELL CULTURE MARKET FOR STEM CELL TECHNOLOGIES, BY REGION,
2018-2023 (USD MILLION) 114
TABLE 126 NORTH AMERICA: CELL CULTURE MARKET FOR STEM CELL TECHNOLOGIES, BY COUNTRY, 2018-2023 (USD MILLION) 114
TABLE 127 EUROPE: CELL CULTURE MARKET FOR STEM CELL TECHNOLOGIES, BY COUNTRY, 2018-2023 (USD MILLION) 115
TABLE 128 CELL CULTURE MARKET FOR DRUG SCREENING & DEVELOPMENT, BY REGION, 2018-2023 (USD MILLION) 115
TABLE 129 NORTH AMERICA: CELL CULTURE MARKET FOR DRUG SCREENING & DEVELOPMENT, BY COUNTRY, 2018-2023 (USD MILLION) 116
TABLE 130 EUROPE: DRUG SCREENING & DEVELOPMENT MARKET, BY COUNTRY,
2018-2023 (USD MILLION) 116
TABLE 131 CELL CULTURE MARKET FOR TISSUE ENGINEERING & REGENERATIVE MEDICINE, BY REGION, 2018-2023 (USD MILLION) 117
TABLE 132 NORTH AMERICA: CELL CULTURE MARKET FOR TISSUE ENGINEERING & REGENERATIVE MEDICINE, BY COUNTRY, 2018-2023 (USD MILLION) 118
TABLE 133 EUROPE: CELL CULTURE MARKET FOR TISSUE ENGINEERING & REGENERATIVE MEDICINE, BY COUNTRY, 2018-2023 (USD MILLION) 118
TABLE 134 CELL CULTURE MARKET FOR OTHER APPLICATIONS, BY REGION,
2018-2023 (USD MILLION) 119
TABLE 135 NORTH AMERICA: CELL CULTURE MARKET FOR OTHER APPLICATIONS,
BY COUNTRY, 2018-2023 (USD MILLION) 120
TABLE 136 EUROPE: CELL CULTURE MARKET FOR OTHER APPLICATIONS, BY COUNTRY,
2018-2023 (USD MILLION) 120
TABLE 137 CELL CULTURE MARKET, BY END USER, 2016–2023 (USD MILLION) 122
TABLE 138 CELL CULTURE MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2016–2023 (USD MILLION) 123
TABLE 139 NORTH AMERICA: CELL CULTURE MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2016–2023 (USD MILLION) 124
TABLE 140 EUROPE: CELL CULTURE MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2016–2023 (USD MILLION) 124
TABLE 141 CELL CULTURE MARKET FOR RESEARCH INSTITUTES, BY REGION,
2016–2023 (USD MILLION) 125
TABLE 142 NORTH AMERICA: CELL CULTURE MARKET FOR RESEARCH INSTITUTES,
BY COUNTRY, 2016–2023 (USD MILLION) 125
TABLE 143 EUROPE: CELL CULTURE MARKET FOR RESEARCH INSTITUTES,
BY COUNTRY, 2016–2023 (USD MILLION) 126
TABLE 144 CELL CULTURE MARKET, BY REGION, 2016–2023 (USD MILLION) 128
TABLE 145 NORTH AMERICA: CELL CULTURE MARKET, BY COUNTRY,
2016–2023 (USD MILLION) 130
TABLE 146 NORTH AMERICA: CELL CULTURE MARKET, BY PRODUCT,
2016–2023 (USD MILLION) 130
TABLE 147 NORTH AMERICA: CELL CULTURE EQUIPMENT MARKET, BY TYPE,
2016–2023 (USD MILLION) 130
TABLE 148 NORTH AMERICA: CELL CULTURE BIOREACTORS MARKET, BY TYPE,
2016–2023 (USD MILLION) 131
TABLE 149 NORTH AMERICA: CELL CULTURE VESSELS MARKET, BY TYPE,
2016–2023 (USD MILLION) 131
TABLE 150 NORTH AMERICA: CELL-CULTURE STORAGE EQUIPMENT MARKET, BY TYPE,
2016–2023 (USD MILLION) 131
TABLE 151 NORTH AMERICA: CELL CULTURE SUPPORTING EQUIPMENT MARKET, BY TYPE, 2016–2023 (USD MILLION) 132
TABLE 152 NORTH AMERICA: CELL CULTURE CONSUMABLES MARKET, BY TYPE,
2016–2023 (USD MILLION) 132
TABLE 153 NORTH AMERICA: CELL CULTURE SERA, MEDIA, AND REAGENTS MARKET, BY TYPE, 2016–2023 (USD MILLION) 133
TABLE 154 NORTH AMERICA: CELL CULTURE SERA MARKET, BY TYPE,
2016–2023 (USD MILLION) 133
TABLE 155 NORTH AMERICA: CELL CULTURE MEDIA MARKET, BY TYPE,
2016–2023 (USD MILLION) 133
TABLE 156 NORTH AMERICA: CELL CULTURE REAGENTS MARKET, BY TYPE,
2016–2023 (USD MILLION) 134
TABLE 157 NORTH AMERICA: CELL CULTURE MARKET, BY APPLICATION,
2016–2023 (USD MILLION) 134
TABLE 158 NORTH AMERICA: CELL CULTURE BIOPHARMACEUTICAL/THERAPEUTIC APPLICATIONS MARKET, BY TYPE, 2016–2023 (USD MILLION) 135
TABLE 159 NORTH AMERICA: CELL CULTURE MARKET, BY END USER,
2016–2023 (USD MILLION) 135
TABLE 160 US: CELL CULTURE MARKET, BY PRODUCT, 2016–2023 (USD MILLION) 136
TABLE 161 US: CELL CULTURE EQUIPMENT MARKET, BY TYPE, 2016–2023 (USD MILLION) 136
TABLE 162 US: CELL CULTURE BIOREACTORS MARKET, BY TYPE, 2016–2023 (USD MILLION) 137
TABLE 163 US: CELL CULTURE VESSELS MARKET, BY TYPE, 2016–2023 (USD MILLION) 137
TABLE 164 US: CELL-CULTURE STORAGE EQUIPMENT MARKET, BY TYPE,
2016–2023 (USD MILLION) 137
TABLE 165 US: CELL CULTURE SUPPORTING EQUIPMENT MARKET, BY TYPE,
2016–2023 (USD MILLION) 138
TABLE 166 US: CELL CULTURE CONSUMABLES MARKET, BY TYPE, 2016–2023 (USD MILLION) 138
TABLE 167 US: CELL CULTURE SERA, MEDIA, AND REAGENTS MARKET, BY TYPE,
2016–2023 (USD MILLION) 139
TABLE 168 US: CELL CULTURE SERA MARKET, BY TYPE, 2016–2023 (USD MILLION) 139
TABLE 169 US: CELL CULTURE MEDIA MARKET, BY TYPE, 2016–2023 (USD MILLION) 139
TABLE 170 US: CELL CULTURE REAGENTS MARKET, BY TYPE, 2016–2023 (USD MILLION) 140
TABLE 171 US: CELL CULTURE MARKET, BY APPLICATION, 2016–2023 (USD MILLION) 140
TABLE 172 US: CELL CULTURE BIOPHARMACEUTICAL/THERAPEUTIC APPLICATIONS MARKET, BY TYPE, 2016–2023 (USD MILLION) 141
TABLE 173 US: CELL CULTURE MARKET, BY END USER, 2016–2023 (USD MILLION) 141
TABLE 174 CANADA: CELL CULTURE MARKET, BY PRODUCT, 2016–2023 (USD MILLION) 142
TABLE 175 CANADA: CELL CULTURE EQUIPMENT MARKET, BY TYPE,
2016–2023 (USD MILLION) 142
TABLE 176 CANADA: CELL CULTURE BIOREACTORS MARKET, BY TYPE,
2016–2023 (USD MILLION) 142
TABLE 177 CANADA: CELL CULTURE VESSELS MARKET, BY TYPE, 2016–2023 (USD MILLION) 143
TABLE 178 CANADA: CELL-CULTURE STORAGE EQUIPMENT MARKET, BY TYPE,
2016–2023 (USD MILLION) 143
TABLE 179 CANADA: CELL CULTURE SUPPORTING EQUIPMENT MARKET, BY TYPE,
2016–2023 (USD MILLION) 144
TABLE 180 CANADA: CELL CULTURE CONSUMABLES MARKET, BY TYPE,
2016–2023 (USD MILLION) 144
TABLE 181 CANADA: CELL CULTURE SERA, MEDIA, AND REAGENTS MARKET, BY TYPE,
2016–2023 (USD MILLION) 145
TABLE 182 CANADA: CELL CULTURE SERA MARKET, BY TYPE, 2016–2023 (USD MILLION) 145
TABLE 183 CANADA: CELL CULTURE MEDIA MARKET, BY TYPE, 2016–2023 (USD MILLION) 145
TABLE 184 CANADA: CELL CULTURE REAGENTS MARKET, BY TYPE, 2015-2022 (USD MILLION) 146
TABLE 185 CANADA: CELL CULTURE MARKET, BY APPLICATION, 2016–2023 (USD MILLION) 146
TABLE 186 CANADA: CELL CULTURE BIOPHARMACEUTICAL/THERAPEUTIC APPLICATIONS MARKET, BY TYPE, 2016–2023 (USD MILLION) 147
TABLE 187 CANADA: CELL CULTURE MARKET, BY END USER, 2016–2023 (USD MILLION) 147
TABLE 188 EUROPE: CELL CULTURE MARKET, BY COUNTRY, 2016–2023 (USD MILLION) 150
TABLE 189 EUROPE: CELL CULTURE MARKET, BY PRODUCT, 2016–2023 (USD MILLION) 150
TABLE 190 EUROPE: CELL CULTURE EQUIPMENT MARKET, BY TYPE,
2016–2023 (USD MILLION) 150
TABLE 191 EUROPE: CELL CULTURE BIOREACTORS MARKET, BY TYPE,
2016–2023 (USD MILLION) 151
TABLE 192 EUROPE: CELL CULTURE VESSELS MARKET, BY TYPE, 2016–2023 (USD MILLION) 151
TABLE 193 EUROPE: CELL-CULTURE STORAGE EQUIPMENT MARKET, BY TYPE,
2016–2023 (USD MILLION) 151
TABLE 194 EUROPE: CELL CULTURE SUPPORTING EQUIPMENT MARKET, BY TYPE,
2016–2023 (USD MILLION) 152
TABLE 195 EUROPE: CELL CULTURE CONSUMABLES MARKET, BY TYPE,
2016–2023 (USD MILLION) 152
TABLE 196 EUROPE: CELL CULTURE SERA, MEDIA, AND REAGENTS MARKET, BY TYPE,
2016–2023 (USD MILLION) 153
TABLE 197 EUROPE: CELL CULTURE SERA MARKET, BY TYPE, 2016–2023 (USD MILLION) 153
TABLE 198 EUROPE: CELL CULTURE MEDIA MARKET, BY TYPE, 2016–2023 (USD MILLION) 153
TABLE 199 EUROPE: CELL CULTURE REAGENTS MARKET, BY TYPE,
2016–2023 (USD MILLION) 154
TABLE 200 EUROPE: CELL CULTURE MARKET, BY APPLICATION, 2016–2023 (USD MILLION) 154
TABLE 201 EUROPE: CELL CULTURE BIOPHARMACEUTICAL/THERAPEUTIC APPLICATIONS MARKET, BY TYPE, 2016–2023 (USD MILLION) 155
TABLE 202 EUROPE: CELL CULTURE MARKET, BY END USER, 2016–2023 (USD MILLION) 155
TABLE 203 GERMANY: CELL CULTURE MARKET, BY PRODUCT, 2016–2023 (USD MILLION) 156
TABLE 204 GERMANY: CELL CULTURE EQUIPMENT MARKET, BY TYPE,
2016–2023 (USD MILLION) 156
TABLE 205 GERMANY: CELL CULTURE CONSUMABLES MARKET, BY TYPE,
2016–2023 (USD MILLION) 157
TABLE 206 GERMANY: CELL CULTURE MARKET, BY APPLICATION, 2016–2023 (USD MILLION) 157
TABLE 207 GERMANY: CELL CULTURE BIOPHARMACEUTICAL/THERAPEUTIC APPLICATIONS MARKET, BY TYPE, 2016–2023 (USD MILLION) 157
TABLE 208 GERMANY: CELL CULTURE MARKET, BY END USER, 2016–2023 (USD MILLION) 158
TABLE 209 FRANCE: CELL CULTURE MARKET, BY PRODUCT, 2016–2023 (USD MILLION) 159
TABLE 210 FRANCE: CELL CULTURE EQUIPMENT MARKET, BY TYPE,
2016–2023 (USD MILLION) 159
TABLE 211 FRANCE: CELL CULTURE CONSUMABLES MARKET, BY TYPE,
2016–2023 (USD MILLION) 159
TABLE 212 FRANCE: CELL CULTURE MARKET, BY APPLICATION, 2016–2023 (USD MILLION) 160
TABLE 213 FRANCE: CELL CULTURE BIOPHARMACEUTICAL/THERAPEUTIC APPLICATIONS MARKET, BY TYPE, 2016–2023 (USD MILLION) 160
TABLE 214 FRANCE: CELL CULTURE MARKET, BY END USER, 2016–2023 (USD MILLION) 160
TABLE 215 UK: CELL CULTURE MARKET, BY PRODUCT, 2016–2023 (USD MILLION) 161
TABLE 216 UK: CELL CULTURE EQUIPMENT MARKET, BY TYPE, 2016–2023 (USD MILLION) 162
TABLE 217 UK: CELL CULTURE CONSUMABLES MARKET, BY TYPE, 2016–2023 (USD MILLION) 162
TABLE 218 UK: CELL CULTURE MARKET, BY APPLICATION, 2016–2023 (USD MILLION) 162
TABLE 219 UK: CELL CULTURE BIOPHARMACEUTICAL/THERAPEUTIC APPLICATIONS MARKET, BY TYPE, 2016–2023 (USD MILLION) 163
TABLE 220 UK: CELL CULTURE MARKET, BY END USER, 2016–2023 (USD MILLION) 163
TABLE 221 ROE: CELL CULTURE MARKET, BY PRODUCT, 2016–2023 (USD MILLION) 164
TABLE 222 ROE: CELL CULTURE EQUIPMENT MARKET, BY TYPE, 2016–2023 (USD MILLION) 164
TABLE 223 ROE: CELL CULTURE CONSUMABLES MARKET, BY TYPE,
2016–2023 (USD MILLION) 165
TABLE 224 ROE: CELL CULTURE MARKET, BY APPLICATION, 2016–2023 (USD MILLION) 165
TABLE 225 ROE: CELL CULTURE BIOPHARMACEUTICAL/THERAPEUTIC APPLICATIONS MARKET, BY TYPE, 2016–2023 (USD MILLION) 165
TABLE 226 ROE: CELL CULTURE MARKET, BY END USER, 2016–2023 (USD MILLION) 166
TABLE 227 ASIA: CELL CULTURE MARKET, BY PRODUCT, 2016–2023 (USD MILLION) 169
TABLE 228 ASIA: CELL CULTURE EQUIPMENT MARKET, BY TYPE, 2016–2023 (USD MILLION) 169
TABLE 229 ASIA: CELL CULTURE BIOREACTORS MARKET, BY TYPE,
2016–2023 (USD MILLION) 169
TABLE 230 ASIA: CELL CULTURE VESSELS MARKET, BY TYPE, 2016–2023 (USD MILLION) 170
TABLE 231 ASIA: CELL CULTURE STORAGE EQUIPMENT MARKET, BY TYPE,
2016–2023 (USD MILLION) 170
TABLE 232 ASIA: CELL CULTURE SUPPORTING EQUIPMENT MARKET, BY TYPE,
2016–2023 (USD MILLION) 171
TABLE 233 ASIA: CELL CULTURE CONSUMABLES MARKET, BY TYPE,
2016–2023 (USD MILLION) 171
TABLE 234 ASIA: CELL CULTURE SERA, MEDIA, AND REAGENTS MARKET, BY TYPE,
2016–2023 (USD MILLION) 172
TABLE 235 ASIA: CELL CULTURE SERA MARKET, BY TYPE, 2016–2023 (USD MILLION) 172
TABLE 236 ASIA: CELL CULTURE MEDIA MARKET, BY TYPE, 2016–2023 (USD MILLION) 172
TABLE 237 ASIA: CELL CULTURE REAGENTS MARKET, BY TYPE, 2016–2023 (USD MILLION) 173
TABLE 238 ASIA: CELL CULTURE MARKET, BY APPLICATION, 2016–2023 (USD MILLION) 173
TABLE 239 ASIA: CELL CULTURE BIOPHARMACEUTICAL/THERAPEUTIC APPLICATIONS MARKET, BY TYPE, 2016–2023 (USD MILLION) 174
TABLE 240 ASIA: CELL CULTURE MARKET, BY END USER, 2016–2023 (USD MILLION) 174
TABLE 241 ROW: CELL CULTURE MARKET, BY PRODUCT, 2016–2023 (USD MILLION) 177
TABLE 242 ROW: CELL CULTURE EQUIPMENT MARKET, BY TYPE, 2016–2023 (USD MILLION) 177
TABLE 243 ROW: CELL CULTURE BIOREACTORS MARKET, BY TYPE,
2016–2023 (USD MILLION) 177
TABLE 244 ROW: CELL CULTURE VESSELS MARKET, BY TYPE, 2016–2023 (USD MILLION) 178
TABLE 245 ROW: CELL CULTURE STORAGE EQUIPMENT MARKET, BY TYPE,
2016–2023 (USD MILLION) 178
TABLE 246 ROW: CELL CULTURE SUPPORTING EQUIPMENT MARKET, BY TYPE,
2016–2023 (USD MILLION) 179
TABLE 247 ROW: CELL CULTURE CONSUMABLES MARKET, BY TYPE,
2016–2023 (USD MILLION) 179
TABLE 248 ROW: CELL CULTURE SERA, MEDIA, AND REAGENTS MARKET, BY TYPE,
2016–2023 (USD MILLION) 180
TABLE 249 ROW: CELL CULTURE SERA MARKET, BY TYPE, 2016–2023 (USD MILLION) 180
TABLE 250 ROW: CELL CULTURE MEDIA MARKET, BY TYPE, 2016–2023 (USD MILLION) 180
TABLE 251 ROW: CELL CULTURE REAGENTS MARKET, BY TYPE, 2016–2023 (USD MILLION) 181
TABLE 252 ROW: CELL CULTURE MARKET, BY APPLICATION, 2016–2023 (USD MILLION) 181
TABLE 253 ROW: CELL CULTURE BIOPHARMACEUTICAL/THERAPEUTIC APPLICATIONS MARKET, BY TYPE, 2016–2023 (USD MILLION) 182
TABLE 254 ROW: CELL CULTURE MARKET, BY END USER, 2016–2023 (USD MILLION) 182
TABLE 255 EXCHANGE RATES (USED FOR THE CONVERSION OF EURO TO USD) 195
TABLE 256 EXCHANGE RATES (USED FOR THE CONVERSION OF CHF TO USD) 206
TABLE 257 EXCHANGE RATES (USED FOR THE CONVERSION OF EURO TO USD) 217
TABLE 258 EXCHANGE RATES (USED FOR THE CONVERSION OF EURO TO USD) 226


LIST OF FIGURES

FIGURE 1 CELL CULTURE MARKET 22
FIGURE 2 RESEARCH DESIGN 24
FIGURE 3 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION 27
FIGURE 4 MARKET SIZE ESTIMATION: BOTTOM-UP APPROACH 29
FIGURE 5 MARKET SIZE ESTIMATION: TOP-DOWN APPROACH 30
FIGURE 6 DATA TRIANGULATION METHODOLOGY 31
FIGURE 7 CELL CULTURE MARKET, BY PRODUCT, 2018 VS. 2023 (USD BILLION) 33
FIGURE 8 CELL CULTURE MARKET, BY APPLICATION, 2018 VS. 2023 (USD BILLION) 34
FIGURE 9 CELL CULTURE MARKET, BY END USER: PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES TO WITNESS THE HIGHEST GROWTH DURING THE FORECAST PERIOD (2018-2023) 35
FIGURE 10 GEOGRAPHICAL SNAPSHOT OF THE CELL CULTURE MARKET 36
FIGURE 11 CELL CULTURE MARKET TO WITNESS DOUBLE-DIGIT GROWTH RATE DURING THE FORECAST PERIOD (2018–2023) 37
FIGURE 12 ROLLER/ROUX BOTTLES COMMANDED THE LARGEST SHARE OF THE EUROPEAN CELL CULTURE VESSELS MARKET IN 2017 38
FIGURE 13 CELL CULTURE MEDIA TO REGISTER THE HIGHEST GROWTH RATE BETWEEN
2018 & 2023 39
FIGURE 14 BIOPHARMACEUTICAL/THERAPEUTIC APPLICATIONS WILL CONTINUE TO DOMINATE THE CELL CULTURE MARKET IN 2023 39
FIGURE 15 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES TO WITNESS THE HIGHEST GROWTH DURING THE FORECAST PERIOD 40
FIGURE 16 ASIA TO REGISTER THE HIGHEST CAGR DURING THE FORECAST PERIOD 40
FIGURE 17 CELL CULTURE MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES 41
FIGURE 18 CONSUMABLES SEGMENT TO DOMINATE THE CELL CULTURE
PRODUCTS MARKET IN 2018 47
FIGURE 19 BIOPHARMACEUTICALS/THERAPEUTIC APPLICATIONS SEGMENT TO DOMINATE CELL CULTURE MARKET DURING THE FORECAST PERIOD (2018-2023) 104
FIGURE 20 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES WILL CONTINUE TO DOMINATE THE CELL CULTURE MARKET IN 2023 122
FIGURE 21 NORTH AMERICA: CELL CULTURE MARKET SNAPSHOT 129
FIGURE 22 EUROPE: CELL CULTURE MARKET SNAPSHOT (2018) 149
FIGURE 23 ASIA: CELL CULTURE MARKET SNAPSHOT 168
FIGURE 24 REST OF THE WORLD (ROW): CELL CULTURE MARKET SNAPSHOT 176
FIGURE 25 KEY PLAYERS ADOPTED ORGANIC AS WELL AS INORGANIC GROWTH STRATEGIES BETWEEN 2014 AND 2018 183
FIGURE 26 MARKET EVOLUTION FRAMEWORK 184
FIGURE 27 GLOBAL CELL CULTURE MARKET SHARE ANALYSIS, BY KEY PLAYER, 2017 185
FIGURE 28 COMPANY SNAPSHOT: THERMO FISHER SCIENTIFIC 189
FIGURE 29 COMPANY SNAPSHOT: MERCK KGAA 194
FIGURE 30 GENERAL ELECTRIC COMPANY: COMPANY SNAPSHOT 201
FIGURE 31 LONZA GROUP AG: COMPANY SNAPSHOT 206
FIGURE 32 CORNING: COMPANY SNAPSHOT 211
FIGURE 33 BECTON, DICKINSON AND COMPANY: COMPANY SNAPSHOT 214
FIGURE 34 EPPENDORF: COMPANY SNAPSHOT 216
FIGURE 35 SARTORIUS AG: COMPANY SNAPSHOT 225
FIGURE 36 COMPANY SNAPSHOT: DANAHER 232

Get in touch!

Looking for sample pages? Or want to speak to someone about discounts?

Please leave your details and we'll get back to you as soon as we can!